错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer

  • Alessandro Alaimo,
  • Sacha Genovesi,
  • Nicole Annesi,
  • Dario De Felice,
  • Saurav Subedi,
  • Alice Macchia,
  • Federico La Manna,
  • Yari Ciani,
  • Federico Vannuccini,
  • Vera Mugoni,
  • Michela Notarangelo,
  • Michela Libergoli,
  • Francesca Broso,
  • Riccardo Taulli,
  • Ugo Ala,
  • Aurora Savino,
  • Martina Cortese,
  • Somayeh Mirzaaghaei,
  • Valeria Poli,
  • Ian Marc Bonapace,
  • Mauro Giulio Papotti,
  • Luca Molinaro,
  • Claudio Doglioni,
  • Orazio Caffo,
  • Adriano Anesi,
  • Michael Nagler,
  • Giovanni Bertalot,
  • Francesco Giuseppe Carbone,
  • Mattia Barbareschi,
  • Umberto Basso,
  • Erik Dassi,
  • Massimo Pizzato,
  • Alessandro Romanel,
  • Francesca Demichelis,
  • Marianna Kruithof-de Julio,
  • Andrea Lunardi

摘要

Inflammation is a common condition of prostate tissue, whose impact on carcinogenesis is highly debated. Microbial colonization is a well-documented cause of a small percentage of prostatitis cases, but it remains unclear what underlies the majority of sterile inflammation reported. Here, androgen- independent fluctuations of PSA expression in prostate cells have lead us to identify a prominent function of the Transient Receptor Potential Cation Channel Subfamily M Member 8 (TRPM8) gene in sterile inflammation. Prostate cells secret TRPM8 RNA into extracellular vesicles (EVs), which primes TLR3/NF-kB-mediated inflammatory signaling after EV endocytosis by epithelial cancer cells. Furthermore, prostate cancer xenografts expressing a translation-defective form of TRPM8 RNA contain less collagen type I in the extracellular matrix, significantly more infiltrating NK cells, and larger necrotic areas as compared to control xenografts. These findings imply sustained, androgen-independent expression of TRPM8 constitutes as a promoter of anticancer innate immunity, which may constitute a clinically relevant condition affecting prostate cancer prognosis.